Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02023242 · ClinicalTrials.gov registry record · NA
Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes
A NA study of Primary Open Angle Glaucoma and Pigmentary Glaucoma, sponsored by Ivantis.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
- 1
- Study location
NCT02023242: Completed NA study of Primary Open Angle Glaucoma and Pigmentary Glaucoma, sponsored by Ivantis.
NCT02023242 is a NA study of Primary Open Angle Glaucoma and Pigmentary Glaucoma that has completed, run by Ivantis. The registered enrollment target is 152 participants, below the 286-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02023242, a NA study of Primary Open Angle Glaucoma and Pigmentary Glaucoma, has completed, sponsored by Ivantis.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial compares two implantable devices intended to lower the pressure inside the eye of glaucoma patients.
Primary Outcome
Percentage of subjects with IOP \</= 19 mmHg and without the use of ocular hypotensive medications at 12 months
Conditions Studied
Interventions
- DEVICE Hydrus Microstent
- DEVICE iStent Trabecular Micro Bypass
Study Locations (1)
California
- Contact Richard Hope at Ivantis - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2012-10 |
| Est. Completion | 2018-01 |
| Phase | NA |
What the finished NCT02023242 record still lists
NCT02023242 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, below the 286-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (47% lower).
The record links to 3 conditions, with Primary Open Angle Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Hydrus Microstent is the first listed.
NCT02023242 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02023242 about?
NCT02023242 is a clinical study titled "Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes". This clinical trial compares two implantable devices intended to lower the pressure inside the eye of glaucoma patients.
What is the current status of trial NCT02023242?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2012-10. Estimated completion is 2018-01.
What conditions does trial NCT02023242 study?
This clinical trial studies the following conditions: Primary Open Angle Glaucoma, Pigmentary Glaucoma, Pseudoexfoliative Glaucoma.
What interventions are being tested in trial NCT02023242?
The interventions under investigation include: Hydrus Microstent (DEVICE), iStent Trabecular Micro Bypass (DEVICE).
Who is sponsoring clinical trial NCT02023242?
This trial is sponsored by Ivantis, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02023242 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02023242's enrollment target sits among peer trials
152 7th of 19 higher than 13 of 19 other Primary Open Angle Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Primary Open Angle Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hydrus® Microstent New Enrollment Post-Approval Study
RECRUITING · NA
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma
RECRUITING · NA
-
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
RECRUITING · NA
-
The Effects of Visior on Ocular Hemodynamics
COMPLETED · NA
-
A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia